Wl. Casley et al., DIFFERENCES IN CAFFEINE 3-DEMETHYLATION ACTIVITY AMONG INBRED MOUSE STRAINS - A COMPARISON OF HEPATIC CYP1A2 GENE-EXPRESSION BETWEEN 2 INBRED STRAINS, Fundamental and applied toxicology, 40(2), 1997, pp. 228-237
The 3-demethylation of caffeine can be used as an index of cytochrome
P450 CYP1A2 activity in vivo. We compared the plasma levels of caffein
e and the 3-demethylated metabolite, 1,7-dimethylxanthine, in six comm
on inbred strains (A/J, P/J, BALB/cJ, C3H/HeJ, AKR/J, and SWR/J) and o
ne inbred strain (APN) derived in our laboratory from outbred Swiss-We
bster mice on the basis of its relative susceptibility to acetaminophe
n-induced hepatotoxicity. We found significant variations between a nu
mber of the common strains, all of which produced significantly higher
caffeine 3-demethylation indices than our APN strain. In three of the
six common strains, there was a significant difference between males
and females, with the females having consistently lower 1,7-xanthine/c
affeine ratios. Hepatic Cyp1a2 expression was compared between APN and
C3H/HeJ males, Microsomal methoxyresorufin O-demethylation, acetanili
de 4-hydroxylation, and CYP1A2 immunoreactive protein levels were sign
ificantly higher in C3H/HeJ relative to APN mice, as were hepatic CYP1
A2 mRNA levels, These results indicate the importance of strain and ge
nder to the outcome of pharmacological or toxicological studies involv
ing CYP1A2-mediated metabolism, as well as the suitability of the plas
ma 1,7-dimethylxanthine/caffeine ratio as a marker of CYP1A2 activity
in the mouse. The striking differences observed between the APN and C3
H/HeJ mice suggest that these strains may be suitable for a genetic an
alysis of the regulation of the basal expression of CYP1A2, a key enzy
me in procarcinogen activation. (C) Society of Toxicology.